IP Library Granted Patent US 10,369,102
Granted Patent B2
US 10,369,102 · App. 15/493,807 · Granted Aug 6, 2019

Wax foamable vehicle and pharmaceutical compositions thereof

Inventors: Dov Tamarkin (Maccabim, IL); Rita Keynan (Rehovot, IL); David Schuz (Gimzu, IL); Tal Berman (Rishon Le Ziyyon, IL)
Assignee: Foamix Pharmaceuticals Ltd.
A61K9/124A61K8/046A61K8/31A61K8/342A61K8/361A61K8/4993A61K8/86A61K9/122A61K47/10A61K47/14A61K47/26A61K47/32A61K47/34A61K47/36A61K47/38A61K47/44A61Q5/006A61Q7/00A61Q19/00A61Q19/02A61Q19/08A61K9/0031A61K9/0034A61K9/0043A61K9/0046A61K9/1075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,102
App. No.
15/493,807
Granted
Aug 6, 2019
Kind
B2
Abstract

Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided. In some embodiments, the wax is a liquid wax. In some embodiments, the wax includes a solid wax and a liquid wax. The compositions are substantially free of crystals. The components are selected to provide a composition that is substantially resistant to aging and to phase separation, and/or can substantially solubilize and or stabilize active ingredients. Pharmaceutical and cosmetic compositions with potentially enhanced skin delivery and their uses are also provided.

Claims (25)

1. A foamble composition comprising a carrier and a liquefied hydrocarbon gas propellant, wherein the carrier comprises:

a) a liquid wax comprising at least one fatty acid and/or at least one fatty alcohol;

b) a non-ionic surface active agent; and

c) water;

wherein the ratio of the carrier to the gas propellant is about 100:3 by weight to about 100:35 by weight;

wherein, upon release from a pressurized container, the foamable composition produces a breakable foam; wherein the carrier does not comprise a polymeric agent selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent, and a phase change agent.

2. The foamable composition of claim 1 , wherein the fatty acid has 12-22 carbon atoms in its carbon backbone.

3. The foamable composition of claim 1 , wherein the fatty alcohol has 12-22 carbon atoms in its carbon backbone.

4. The foamable composition of claim 1 , wherein the fatty acid has 16-22 carbon atoms in its carbon backbone.

5. The foamable composition of claim 1 , wherein the fatty alcohol has 16-22 carbon atoms in its carbon backbone.

6. The foamable composition of claim 1 , wherein the fatty alcohol is a branched and/or unsaturated fatty alcohol.

7. The foamable composition of claim 1 , wherein the fatty acid is a branched and/or unsaturated fatty acid.

8. The foamable composition of claim 1 , wherein the liquid wax is present at a concentration of at least about 7.5% to about 60% by weight and comprises isostearic acid, myristoleic acid, palmitoleic acid, oleic acid, linoleic acid, alpha linolenic acid, arachidonic acid, eicosapentaenoic acid, erucic acid, docosahexaenoic acid, isostearyl alcohol, oleyl alcohol, lauric acid, octyldodecanol, jojoba oil, or a mixture of two or more thereof.

9. The foamable composition of claim 1 , wherein the carrier comprises a fatty acid and a fatty alcohol, and wherein the ratio of the amount by weight of the carrier of the fatty alcohol to that of the fatty acid is between about 10:9 and about 8:1.

10. The foamable composition of claim 1 , wherein the surface active agent is present at between about 0.2% and about 8% by weight of the carrier.

11. The foamable composition of claim 10 , wherein the surface active agent is selected from the group consisting of a polysorbate, polyoxyethylene (20) sorbitan monostearate, polyoxyethylene (20) sorbitan monooleate, a polyoxyethylene fatty acid ester, polyoxyethylene (8) stearate, polyoxyethylene (20) stearate, polyoxyethylene (40) stearate, polyoxyethylene (100) stearate, a polyoxyethylene alkyl ether, a polyoxyethylene cetyl ether, polyoxyethylene (23) cetyl ether, polyoxyethylene (2) cetyl ether, polyoxyethylene (10) cetyl ether, a sucrose ester, a partial ester of sorbitol, sorbitan monolaurate, a monoglyceride, a diglyceride, isoceteth-20, steareth 2, glyceryl stearate, steareth-21, sorbitan stearate, laureth 4, sorbitan monooleate, ceteareth 20, steareth 20, ceteth 20, macrogol cetostearyl ether, PEG-30 di polyhydroxystearate, sucrose distearate, cetomacrogol ether, cetearyl glucoside, polysorbate 20; methyl glucose sesquistearate, a sucrose stearic acid ester, a phospholipid, and a mixture of two or more thereof.

12. The foamable composition of claim 1 , further comprising a solvent selected from the group consisting of an organic carrier, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and a mixture of two or more thereof.

13. The foamable composition of claim 12 , wherein the organic carrier is selected from the group consisting of mineral oil, triglyceride, medium chain triglyceride (MCT) oil, capric/caprylic triglyceride, alkyl esters of fatty acids isopropyl palmitate, isopropyl myristate, isopropyl isostearate, poly propylene glycol 15-stearly ether, octyl palmitate, cetyl lactate, cetyl ricinoleate, tocopheryl acetate, acetylated lanolin alcohol, cetyl acetate, phenyl trimethicone, glyceryl oleate, tocopheryl linoleate, wheat germ glycerides, arachidyl propionate, myristyl lactate, decyl oleate, ricinoleate, isopropyl lanolate, pentaerythrityl tetrastearate, neopentylglycol dicaprylate/dicaprate, isononyl isononanoate, isotridecyl isononanoate, myristyl myristate, triisocetyl citrate, octyl dodecanol, maleated soybean oil, unsaturated or polyunsaturated oils, olive oil, corn oil, soybean oil, canola oil, cottonseed oil, coconut oil, sesame oil, sunflower oil, borage seed oil, syzigium aromaticum oil, hempseed oil, herring oil, cod-liver oil, salmon oil, flaxseed oil, wheat germ oil, evening primrose oil, essential oil, silicone oil, dimethicone, cyclomethicone, polyalkyl siloxane, polyaryl siloxane, polyalkylaryl siloxane, a polyether siloxane copolymer, a poly(dimethylsiloxane)-(diphenyl-siloxane), and a mixture of two or more thereof.

14. The foamable composition of claim 12 , wherein the polar solvent is selected from the group consisting of dimethyl isosorbide, glycerol, propylene glycol, hexylene glycol, diethylene glycol, propylene glycol n-alkanols, terpenes, di-terpenes, tri-terpenes, limonene, terpene-ol, 1-menthol, dioxolane, ethylene glycol, oleyl alcohol, alpha-hydroxy acids, lactic acid, glycolic acid, sulfoxides, dimethylsulfoxide (DMSO), dimethylformanide, methyl dodecyl sulfoxide, dimethylacetamide, azone (1-dodecylazacycloheptan-2-one), 2-(n-nonyl)-1,3-dioxolane, alkanols, dialkylamino acetates, and a mixture of two or more thereof.

15. The foamable composition of claim 1 , further comprising a modulating agent, an anti-perspirant, an anti-static agent, a buffering agent, a bulking agent, a chelating agent, a colorant, a conditioner, a deodorant, a diluent, a dye, an emollient, fragrance, a humectant, an occlusive agent, a penetration enhancer, a perfuming agent, a permeation enhancer, a pH-adjusting agent, a preservative, a skin penetration enhancer, a sunscreen, a sun blocking agent, a sunless tanning agent, a vitamin, or a mixture of two or more thereof.

16. The foamable composition of claim 1 , further comprising an active agent.

17. The foamable composition of claim 16 , wherein the active agent is selected from the group consisting of an active herbal extract, an acaricide, an age spot and keratose removing agent, an allergen, an analgesic, a local anesthetic, an antiacne agent, an antiallergic agent, an antiaging agent, an antibacterial, an antibiotic, an antiburn agent, an anticancer agent, an antidandruff agent, an antidepressant, an antidermatitis agent, an antiedemic, an antihistamine, an antihelminth, an antihyperkeratolyte agent, an antiinflammatory agent, an antiirritant, an antilipemic, an antimicrobial, an antimycotic, an antiproliferative agent, an antioxidant, an anti-wrinkle agent, an antipruritic, an antipsoriatic agent, an antirosacea agent, an antiseborrheic agent, an antiseptic agent, an antiswelling agent, an antiviral agent, an antiyeast agent, an astringent, a topical cardiovascular agent, a chemotherapeutic agent, a corticosteroid, a dicarboxylic acid, a disinfectant, a fungicide, a hair growth regulator, a hormone, a hydroxy acid, an immunosuppressant, an immunoregulating agent, an immunomodulatory, an insecticide, an insect repellent, a keratolytic agent, a lactam, a metal oxide, a mitocide, a neuropeptide, a steroid, a non-steroidal anti-inflammatory agent, an oxidizing agent, a pediculicide, a photodynamic therapy agent, a retinoid, a sanative, a scabicide, a vasoconstrictor, a vasodilator, a vitamin, a vitamin D derivative, niacinamide, a wound healing agent, a wart remover; an agent having activity against superficial basal cell carcinomas, actinic keratoses, Bowen's disease, or other squamous cell carcinomas and molluscum contagiosum; an agent having activity against herpes simplex virus infections, other viral infections, or eczema; and a mixture of two or more thereof.

18. A method of treating or ameliorating a skin, mucosal or body cavity disorder of a subject, comprising topically administering to the subject a foam produced from the foamable composition of claim 16 , wherein the disorder is selected from the group consisting of dermatological inflammation, acne, acne vulgaris, inflammatory acne, non-inflammatory acne, nodular papulopustular acne, dermatitis, bacterial skin infections, hidradenitis suppurativa, molluscum contagiosum, psoriasis, pityriasis rubra pilaris, sunburn, photosensitivity, keratosis pilaris, ichthyosis, rosacea, aging skin, wrinkles, and sun spots.

19. The foamable composition of claim 17 , wherein the active agent is a combination of a retinoid and niacinamide.

20. A method of treating or ameliorating a skin, mucosal or body cavity disorder of a subject, comprising topically administering to the subject a foam produced from the foamable composition of claim 16 , wherein the disorder is selected from the group consisting of external genital and perianal warts, superficial basal cell carcinomas, actinic keratoses, skin neoplasia, and melanoma.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0708 →
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE PHARMACEUTICALS LTD. (F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0138 →
PATENT SECURITY AGREEMENT Recorded Feb 17, 2021
From: VYNE THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 055326/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: VYNE PHARMACEUTICALS LTD.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055215/0298 →
CHANGE OF NAME Recorded Nov 4, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: VYNE PHARMACEUTICALS LTD.
Reel/Frame 054306/0387 →
PATENT SECURITY AGREEMENT Recorded Jul 30, 2019
From: FOAMIX PHARMACEUTICALS LTD
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 049912/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2019
From: TAMARKIN, DOV; KEYNAN, RITA; SCHUZ, DAVID; BERMAN, TAL
To: FOAMIX LTD.
Reel/Frame 048427/0077 →
CHANGE OF NAME Recorded Feb 25, 2019
From: FOAMIX, LTD.
To: FOAMIX PHARMACEUTICALS, LTD.
Reel/Frame 048429/0052 →
Continuity (3)
Continuation 14161134 · Jan 22, 2014
Continuation 12187840 · Aug 7, 2008
Related Publication 20180000734A1 · Jan 4, 2018
Cited By (1)
US 12,661,407